![]() |
![]() |
Psychiatry Investig > Volume 22(1); 2025 > Article |
|
Availability of Data and Material
The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.
Conflicts of Interest
Seung Jae Lee, a contributing editor of the Psychiatry Investigation, was not involved in the editorial evaluation or decision to publish this article. All remaining authors have declared no conflicts of interest.
Author Contributions
Conceptualization: Seung Jae Lee, Sang Won Lee. Data curation: all authors. Formal analysis: Seung Jae Lee, Sang Won Lee. Funding acquisition: Seung Jae Lee. Investigation: all authors. Methodology: Seung Jae Lee, Sang Won Lee. Writing—original draft: Seung Jae Lee, Sang Won Lee. Writing—review & editing: Seung Jae Lee.
Funding Statement
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) [grant numbers 2021R1A2C2004720].
Characteristics | MDD (N=34) | OCD (N=43) | HC (N=46) | F/χ2 | p | Post-hoc* |
---|---|---|---|---|---|---|
Age (yr) | 25.4±5.1 | 26.4±6.4 | 27.9±6.1 | 1.7 | 0.195 | ‒ |
Male/female | 11/23 | 22/21 | 22/24 | 3.0 | 0.223 | ‒ |
Level of education (yr) | 14.6±1.7 | 14.5±1.7 | 14.8±1.5 | 0.5 | 0.611 | ‒ |
Age at onset of illness (yr) | 20.7±6.0 | 18.9±5.4 | ‒ | 1.8 | 0.185 | ‒ |
Duration of illness (yr) | 5.1±4.6 | 7.5±5.9 | ‒ | 4.0 | 0.050 | ‒ |
Symptom measure | ||||||
CES-D | 29.2±12.8 | 18.3±9.9 | 6.4±6.5 | 59.0 | <0.0001 | MDD>OCD>HC |
Y-BOCS | 6.5±7.4 | 23.1±6.3 | 3.1±4.4 | 122.5 | <0.0001 | OCD>MDD>HC |
Transdiagnostic measure | ||||||
AAQ-II | 38.6±7.9 | 35.1±10.0 | 19.1±7.3 | 62.7 | <0.0001 | MDD, OCD>HC |
CFQ | 33.7±10.1 | 34.4±9.9 | 15.9±6.7 | 60.1 | <0.0001 | MDD, OCD>HC |
TAFS-M | 20.2±11.0 | 20.7±11.3 | 18.4±10.4 | 0.6 | 0.575 | ‒ |
TAFS-L | 8.2±7.8 | 8.8±6.9 | 4.7±5.3 | 5.0 | 0.009 | MDD, OCD>HC |
AAQ-OC | 45.6±14.4 | 61.7±12.4 | 29.0±10.6 | 78.9 | <0.0001 | OCD>MDD>HC |
MDD, major depressive disorder; OCD, obsessive-compulsive disorder; HC, healthy control; CES-D, Center for Epidemiologic Studies Depression Scale; Y-BOCS, Yale-Brown Obsessive-Compulsive Scale; AAQ-II, Acceptance and Action Questionnaire-II; CFQ, Cognitive Fusion Questionnaire; TAFS-M, -L, Thought-Action Fusion Scale-Moral, -Likelihood; AAQ-OC, Acceptance and Action Questionnaire for Obsessions and Compulsions
MDD, major depressive disorder; OCD, obsessive-compulsive disorder; HC, healthy control; CES-D, Center for Epidemiologic Studies Depression Scale; Y-BOCS, Yale-Brown Obsessive-Compulsive Scale; AAQ-II, Acceptance and Action Questionnaire-II; CFQ, Cognitive Fusion Questionnaire; TAFS-M, -L, Thought-Action Fusion Scale-Moral, -Likelihood; AAQ-OC, Acceptance and Action Questionnaire for Obsessions and Compulsions
MDD, major depressive disorder; OCD, obsessive-compulsive disorder; HC, healthy control; CES-D, Center for Epidemiologic Studies Depression Scale; Y-BOCS, Yale-Brown Obsessive-Compulsive Scale; AAQ-II, Acceptance and Action Questionnaire-II; CFQ, Cognitive Fusion Questionnaire; TAFS-L, Thought-Action Fusion Scale-Likelihood
MDD, major depressive disorder; OCD, obsessive-compulsive disorder; HC, healthy control; CES-D, Center for Epidemiologic Studies Depression Scale; Y-BOCS, Yale-Brown Obsessive-Compulsive Scale; AAQ-OC, Acceptance and Action Questionnaire for Obsessions and Compulsions; CFQ, Cognitive Fusion Questionnaire; TAFS-L, Thought-Action Fusion Scale-Likelihood
![]() |
![]() |